Beijing Wantai Biological Pharmacy Enterprise Dividend
Dividend criteria checks 1/6
Beijing Wantai Biological Pharmacy Enterprise is a dividend paying company with a current yield of 0.47%.
Key information
0.5%
Dividend yield
-205%
Payout ratio
Industry average yield | 1.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.320 |
Earnings per share | -CN¥0.15 |
Dividend yield forecast | 0.4% |
Recent dividend updates
No updates
Recent updates
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) Analysts Are Reducing Their Forecasts For This Year
Jul 26These 4 Measures Indicate That Beijing Wantai Biological Pharmacy Enterprise (SHSE:603392) Is Using Debt Reasonably Well
Jul 22Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings
Apr 04Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade
Apr 02Earnings Tell The Story For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) As Its Stock Soars 27%
Feb 28Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 603392 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 603392's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
Beijing Wantai Biological Pharmacy Enterprise Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (603392) | 0.5% |
Market Bottom 25% (CN) | 0.8% |
Market Top 25% (CN) | 2.8% |
Industry Average (Biotechs) | 1.4% |
Analyst forecast (603392) (up to 3 years) | 0.4% |
Notable Dividend: 603392's dividend (0.47%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.75%).
High Dividend: 603392's dividend (0.47%) is low compared to the top 25% of dividend payers in the CN market (2.75%).
Earnings Payout to Shareholders
Earnings Coverage: 603392 is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (82.5%), 603392's dividend payments are covered by cash flows.